IN8bio, Inc.

NasdaqGM:INAB Voorraadrapport

Marktkapitalisatie: US$22.0m

IN8bio Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

William Ho

Algemeen directeur

US$1.9m

Totale compensatie

Percentage CEO-salaris30.8%
Dienstverband CEO9yrs
Eigendom CEO3.9%
Management gemiddelde ambtstermijn5yrs
Gemiddelde ambtstermijn bestuur4.2yrs

Recente managementupdates

Recent updates

IN8bio (NASDAQ:INAB) Will Have To Spend Its Cash Wisely

Aug 06
IN8bio (NASDAQ:INAB) Will Have To Spend Its Cash Wisely

We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate

Apr 03
We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate

Companies Like IN8bio (NASDAQ:INAB) Could Be Quite Risky

Nov 04
Companies Like IN8bio (NASDAQ:INAB) Could Be Quite Risky

Is IN8bio (NASDAQ:INAB) In A Good Position To Invest In Growth?

Jan 26
Is IN8bio (NASDAQ:INAB) In A Good Position To Invest In Growth?

Here's Why We're Watching IN8bio's (NASDAQ:INAB) Cash Burn Situation

Oct 12
Here's Why We're Watching IN8bio's (NASDAQ:INAB) Cash Burn Situation

IN8bio gains 53% as H.C. Wainwright initiates with Buy

Aug 30

IN8bio raises additional funds from underwriter of stock offering

Aug 19

IN8bio prices $10.25M stock offering

Aug 12

We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate

Jun 04
We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate

IN8bio (NASDAQ:INAB) Is In A Good Position To Deliver On Growth Plans

Feb 13
IN8bio (NASDAQ:INAB) Is In A Good Position To Deliver On Growth Plans

IPO Update: IN8bio Aims For Downsized IPO

Jul 29

Analyse CEO-vergoeding

Hoe is William Ho's beloning veranderd ten opzichte van IN8bio's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

-US$32m

Jun 30 2024n/an/a

-US$32m

Mar 31 2024n/an/a

-US$31m

Dec 31 2023US$2mUS$572k

-US$30m

Sep 30 2023n/an/a

-US$30m

Jun 30 2023n/an/a

-US$30m

Mar 31 2023n/an/a

-US$30m

Dec 31 2022US$2mUS$550k

-US$29m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$23m

Mar 31 2022n/an/a

-US$18m

Dec 31 2021US$2mUS$446k

-US$15m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$1mUS$279k

-US$10m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$6m

Dec 31 2019US$214kUS$214k

-US$6m

Compensatie versus markt: De totale vergoeding ($USD 1.85M ) William } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 646.00K ).

Compensatie versus inkomsten: De vergoeding van William is gestegen terwijl het bedrijf verliesgevend is.


CEO

William Ho (47 yo)

9yrs

Tenure

US$1,854,166

Compensatie

Mr. William Ho, also known as Will, is the Co-Founder of IN8bio, Inc. and has been President, Chief Executive Officer and Director since November 2015 and had been its Chief Financial Officer since October...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Tai-Wei Ho
Co-Founder9yrsUS$1.85m3.87%
$ 851.7k
Patrick McCall
CFO & Secretary3.8yrsUS$914.84k0.072%
$ 15.8k
Lawrence Lamb
Executive VP6yrsUS$918.75k0.14%
$ 30.8k
Kate Rochlin
Chief Operating Officer3.9yrsUS$934.68k0.059%
$ 13.0k

5.0yrs

Gemiddelde duur

44.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van INAB wordt beschouwd als ervaren (gemiddelde ambtstermijn 5 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Tai-Wei Ho
Co-Founder9yrsUS$1.85m3.87%
$ 851.7k
Peter Brandt
Independent Director5.3yrsUS$195.42k0.86%
$ 189.2k
Alan Roemer
Independent Chairman of the Board4.2yrsUS$256.42k0.39%
$ 86.6k
Emily Fairbairn
Independent Director3.3yrsUS$172.92k4.61%
$ 1.0m
Marcela Maus
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Travis Whitfill
Independent Director4.2yrsUS$163.67k0%
$ 0
Luba Greenwood
Independent Director3.3yrsUS$181.42k0.011%
$ 2.4k
Bruce Levine
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Siraj Ali
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Bianca Santomasso
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Dieter Kabelitz
Member of Scientific Advisory boardno datageen gegevensgeen gegevens
Michael Bishop
Member of Scientific Advisory Board2.2yrsgeen gegevensgeen gegevens

4.2yrs

Gemiddelde duur

47yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van INAB wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).